EUVIMEDEUVIMED entdecken
Crossref

Delivery of SiRNA-PD-L1 by attenuated Salmonella in combination with oxaliplatin in a hepatocellular carcinoma mouse model

Pengfei Chen, Jinwei Chen, Baozhu Li, Yige Zhang, Kun Li, Chuyang Shao, Panpan Guo, Tongguo Yang, Hongjun Liu, Xiaolong Jia, Xuhua Duan, Tiesuo Zhao und 2 weitere

International Immunopharmacology · 2024

DOI: 10.1016/j.intimp.2024.112892 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2024. Verfasst von Pengfei Chen und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, P.R. China. Hauptthemen laut MEDLINE: Oxaliplatin, B7-H1 Antigen, RNA, Small Interfering, Carcinoma, Hepatocellular. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Health Commission of Henan Province, Zhengzhou University First Affiliated Hospital, Special Fund Project for Science and Technology Innovation Strategy of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oxaliplatin is currently used for chemotherapy in patients with hepatocellular carcinoma, but its increasing tolerance to tumours over time limits its clinical application. Studies have shown that high PD-L1 expression promotes the polarization of M2 macrophages. The increased infiltration of M2 macrophages, including those in HCC, is positively correlated with poor prognosis in various solid tumours. We found that oxaliplatin promoted the expression of PD-L1 in liver cancer cells, which might be attributed partly to the tolerance of tumours to oxaliplatin. Therefore, in this study, we explored the antitumour effect of attenuated Salmonella carrying siRNA-PD-L1 combined with oxaliplatin via Western blotting, immunohistochemistry, immunofluorescence, and flow cytometry. The results revealed that attenuated Salmonella carrying siRNA-PD-L1 combined with oxaliplatin more significantly inhibited tumour growth in tumour-bearing mice, suppressed the expression of PD-L1 in tumour tissue, increased the apoptosis of tumour cells and the expression of the tumour-related protein cleaved-caspase3, and increased the infiltration of M1 macrophages and T lymphocytes in tumour tissues. Moreover, the combination therapy increased the activation of T cells and the number of T lymphocytes and NK cells in the spleens of the mice and improved the overall antitumour immune response in the mice. Our results confirmed that attenuated Salmonella harbouring siRNA-PD-L1 combined with oxaliplatin had a significant antitumour effect and did not increase the incidence of toxic side effects, providing a theoretical reference for addressing oxaliplatin tolerance in the treatment of hepatocellular carcinoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OxaliplatinB7-H1 AntigenRNA, Small InterferingCarcinoma, HepatocellularLiver NeoplasmsAnimalsMiceHumansAntineoplastic AgentsMacrophagesCell Line, TumorApoptosisSalmonellaMice, Inbred BALB CMaleCombined Modality TherapyDisease Models, AnimalT-Lymphocytes

Stichwörter der Autor:innen

HepatocellularOxaliplatinPD-L1RNAiSalmonella

Substanzen

OxaliplatinB7-H1 AntigenRNA, Small InterferingAntineoplastic AgentsCd274 protein, mouse

Autor:innen und Institutionen

  • Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, P.R. China.
  • Xinxiang Engineering Technology Research Center of Immune Checkpoint Drug for Liver-Intestinal Tumors, Xinxiang Medical University, Xinxiang, Henan 453000, P.R. China; Xinxiang Key Laboratory of Tumor Vaccine and Immuno…
  • Chinese Medicine Hospital of Puyang, Puyang, Henan 457001, P.R. China.
  • Department of Microbiology, Medical College, Xinxiang University, Xinxiang, Henan 453000, P.R. China.
  • Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, P.R. China. Electronic address: zhongziqi1115@163.com.

Förderung

  • Health Commission of Henan Province
  • Zhengzhou University First Affiliated Hospital
  • Special Fund Project for Science and Technology Innovation Strategy of Guangdong Province
  • Innovation Scientists and Technicians Troop Construction Projects of Henan Province
  • Xinxiang Medical University

Zitieren

APA

Chen, P., Chen, J., Li, B., Zhang, Y., Li, K., Shao, C., Guo, P., Yang, T., Liu, H., Jia, X., Duan, X., Zhao, T., Jia, H., & Ren, J. (2024). Delivery of SiRNA-PD-L1 by attenuated Salmonella in combination with oxaliplatin in a hepatocellular carcinoma mouse model. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2024.112892

Vancouver

Chen P, Chen J, Li B, Zhang Y, Li K, Shao C, et al. Delivery of SiRNA-PD-L1 by attenuated Salmonella in combination with oxaliplatin in a hepatocellular carcinoma mouse model. International Immunopharmacology. 2024. doi:10.1016/j.intimp.2024.112892

BibTeX
@article{Chen2024,
  author = {Chen, Pengfei and Chen, Jinwei and Li, Baozhu and Zhang, Yige and Li, Kun and Shao, Chuyang and Guo, Panpan and Yang, Tongguo and Liu, Hongjun and Jia, Xiaolong and Duan, Xuhua and Zhao, Tiesuo and Jia, Huijie and Ren, Jianzhuang},
  title = {Delivery of SiRNA-PD-L1 by attenuated Salmonella in combination with oxaliplatin in a hepatocellular carcinoma mouse model},
  journal = {International Immunopharmacology},
  year = {2024},
  doi = {10.1016/j.intimp.2024.112892}
}
Kostenlos starten →